arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Omada Health, Inc.

OMDA Health Care Medical/Nursing Services
$22.77
Today
as of Sep 4, 16:52 ET
Last 30 days +10.64% Jul 27 → Sep 04
$18.64 $20.34 $22.05 $23.76 $25.46 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$22.12
High
$22.97
Low
$21.86
Volume
$877,384
Avg Vol
$1M
Mkt Cap
$1.5B
P/E (TTM)
—
Beta
—
52w High
$26.91
52w Low
$10.28
Div Yield
—
Shares Out
$61M

Recent Press Releases & News last 60 days · 15 items

Aug 13 · 22:32 Motley Fool
Omada Health (OMDA) Q2 2026 Earnings Call Transcript
Aug 12 · 20:51 MT Newswires
Omada Health Insider Sold Shares Worth $421,547, According to a Recent SEC Filing
Aug 11 · 13:04 MarketBeat
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
▸ Show all 15 press releases & news Free account →

Overview

52-week range
$10
$27
75% of range
Avg surprise (last 2)
-4.6%
Avg reaction (last 1)
+3.4%
100% positive
Latest IV / EM
56%
EM ±8.7% · $23 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.40$-1.03$-0.66$-0.29$0.08 Actual $-1.40Actual $-1.18Actual $-1.15Actual $-0.22Est $-0.15Actual $-0.06Actual $-0.05Est $-0.08Actual $0.08 JunSepMarJun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-9M$16M$41M$67M$92M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.08 — — — — financials
Thu May 7, 2026Mar/2026 $-0.05 $-0.08 +37.5% — +3.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.06 — — — — financials
Thu Aug 7, 2025Jun/2025 $-0.22 $-0.15 -46.7% — — earnings
Mon Mar 31, 2025Mar 2025 $-1.15 — — — — financials
Mon Sep 30, 2024Sep 2024 $-1.18 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.40 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$88M$78M—$68M$61M$55M—$46M
Cost of revenue$24M$29M—$23M$21M$23M—$17M
Gross profit$64M$49M—$45M$40M$32M—$29M
Operating income$4M$-5M—$-3M$-4M$-8M—$-9M
Net income$5M$-3M—$-3M$-5M$-9M—$-9M
EPS (diluted)$0.08$-0.05—$-0.06$-0.24$-1.15—$-1.18

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$222M$212M$222M$199M$223M—$76M—
Inventory$4M$4M$4M$3M$3M—$3M—
Total current assets$295M$269M$273M$255M$271M—$113M—
Total assets$328M$303M$305M$287M$303M—$151M—
Long-term debt———$0$30M—$30M—
Total liabilities$75M$69M$76M$70M$89M—$86M—
Total equity$253M$234M$230M$217M$214M$-390M$-384M$-380M

Implied volatility — last 90 days

55%126%196%267%338% Jun 07 — IV 73% · EM ±10.2%Jun 08 — IV 100% · EM ±13.1%Jun 09 — IV 78% · EM ±9.7%Jun 10 — IV 68% · EM ±8.0%Jun 11 — IV 92% · EM ±10.2%Jun 12 — IV 100% · EM ±10.2%Jun 15 — IV 76% · EM ±5.5%Jun 16 — IV 173% · EM ±10.2%Jun 17 — IV 146% · EM ±6.1%Jun 19 — IV 72% · EM ±15.9%Jun 22 — IV 61% · EM ±12.8%Jun 23 — IV 66% · EM ±13.5%Jun 24 — IV 71% · EM ±14.3%Jun 26 — IV 70% · EM ±13.4%Jun 29 — IV 57% · EM ±10.0%Jun 30 — IV 73% · EM ±12.6%Jul 01 — IV 56% · EM ±9.4%Jul 02 — IV 80% · EM ±13.0%Jul 03 — IV 83% · EM ±13.0%Jul 06 — IV 55% · EM ±7.7%Jul 07 — IV 60% · EM ±7.9%Jul 08 — IV 69% · EM ±8.6%Jul 09 — IV 71% · EM ±8.4%Jul 10 — IV 86% · EM ±9.4%Jul 13 — IV 125% · EM ±10.4%Jul 14 — IV 136% · EM ±9.8%Jul 15 — IV 261% · EM ±15.4%Jul 16 — IV 339% · EM ±14.1%Jul 20 — IV 72% · EM ±17.0%Jul 21 — IV 65% · EM ±15.1%Jul 22 — IV 63% · EM ±14.3%Jul 23 — IV 84% · EM ±18.9%Jul 24 — IV 66% · EM ±14.6%Jul 27 — IV 68% · EM ±14.2%Jul 28 — IV 69% · EM ±14.2%Jul 29 — IV 86% · EM ±17.2%Jul 30 — IV 81% · EM ±15.9%Jul 31 — IV 71% · EM ±13.6%Aug 03 — IV 106% · EM ±18.8%Aug 04 — IV 94% · EM ±16.1%Aug 05 — IV 95% · EM ±15.8%Aug 06 — IV 89% · EM ±14.5%Aug 07 — IV 92% · EM ±14.4%Aug 10 — IV 73% · EM ±10.1%Aug 11 — IV 67% · EM ±8.8%Aug 12 — IV 126% · EM ±15.7%Aug 13 — IV 67% · EM ±7.9%Aug 14 — IV 86% · EM ±9.5%Aug 17 — IV 199% · EM ±16.6%Aug 18 — IV 212% · EM ±15.4%Aug 19 — IV 225% · EM ±13.3%Aug 20 — IV 308% · EM ±12.9%Aug 24 — IV 71% · EM ±14.9%Aug 25 — IV 72% · EM ±14.8%Aug 26 — IV 80% · EM ±16.0%Aug 27 — IV 75% · EM ±14.7%Aug 28 — IV 68% · EM ±13.1%Aug 31 — IV 66% · EM ±11.6%Sep 01 — IV 73% · EM ±12.6%Sep 02 — IV 99% · EM ±16.5%Sep 03 — IV 60% · EM ±9.6%Sep 04 — IV 56% · EM ±8.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in